文献速递乳腺技术与安全MR

合成MRI定量参数用于鉴别浸润性乳腺癌腋窝淋巴结状态的研究

Investigation of synthetic MRI with quantitative parameters for discriminating axillary lymph nodes status in invasive breast cancer.
PubMed 文献 · Eur J Radiol · 2024-04-04

本研究纳入56例经病理证实为浸润性乳腺癌的女性,其中腋窝淋巴结转移30例、非转移26例,均行常规乳腺MRI及额外合成MRI检查。结果显示淋巴结短径鉴别转移的AUC为0.894,T1LN为腋窝淋巴结转移的唯一独立预测因子(OR=1.426),联合参数AUC最高达0.964。

要点

  • 淋巴结短径鉴别腋窝淋巴结转移的AUC为0.894,最佳截断值5.78 mm,敏感度86.7%、特异度90.2%。
  • T1LN是腋窝淋巴结转移的唯一独立预测因子(OR=1.426,95%CI 1.130-1.798,P=0.039)。
  • T1LN、T2LN、T1LN/T2LN、ΔT1LN与淋巴结短径联合鉴别转移的AUC最高为0.964。

核心结论

  • 合成MRI定量参数对鉴别浸润性乳腺癌腋窝淋巴结状态有一定价值,乳腺病灶参数中T2tumor诊断效能最高,T1LN为腋窝淋巴结转移的独立预测因子。

研究设计与样本

  • 研究纳入56例经组织病理学证实为浸润性乳腺癌的女性,均行常规乳腺MRI及额外合成MRI检查,其中腋窝淋巴结转移30例、非转移26例。

诊断标准与关键数值

  • 淋巴结短径鉴别腋窝淋巴结转移的最佳截断值为5.78 mm,AUC为0.894(95%CI 0.838-0.939),敏感度86.7%、特异度90.2%。
  • T2tumor鉴别腋窝淋巴结状态的最佳截断值为90.12 ms,AUC为0.712,敏感度65.0%、特异度83.6%。
  • T1LN、T2LN、T1LN/T2LN、T2+LN、ΔT1LN的AUC分别为0.785、0.840、0.886、0.702、0.754。
  • T1LN最佳截断值1371.00 ms时,诊断敏感度86.7%、特异度69.4%。
  • T1LN、T2LN、T1LN/T2LN、ΔT1LN与淋巴结短径联合鉴别的AUC分别为0.905、0.957、0.964、0.897。

临床应用与阅片要点

  • 合成MRI可定量测量T1、T2及质子密度值,测量对象包括乳腺原发肿瘤与腋窝淋巴结,并计算注射对比剂前后的差值及比值。
  • T1LN为腋窝淋巴结转移的独立预测因子(OR=1.426,95%CI 1.130-1.798,P=0.039)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the potential value of quantitative parameters derived from synthetic magnetic resonance imaging (syMRI) for discriminating axillary lymph nodes metastasis (ALNM) in breast cancer patients.

MATERIALS AND METHODS: A total of 56 females with histopathologically proven invasive breast cancer who underwent both conventional breast MRI and additional syMRI examinations were enrolled in this study, including 30 patients with ALNM and 26 with non-ALNM. SyMRI has enabled quantification of T1 relaxation time (T1), T2 relaxation time (T2) and proton density (PD). The syMRI quantitative parameters of breast primary tumors before (T1tumor, T2tumor, PDtumor) and after (T1+tumor, T2+tumor, PD+tumor) contrast agent injection were obtained. Similarly, measurements were taken for axillary lymph nodes before (T1LN, T2LN, PDLN) and after (T1+LN, T2+LN, PD+LN) the injection, then theΔT1 (T1-T1+), ΔT2 (T2-T2+), ΔPD (PD-PD+), T1/T2 and T1+/T2+ were calculated. All parameters were compared between ANLM and non-ALNM group. Intraclass correlation coefficient for assessing interobserver agreement. The independent Student's t test or Mann-Whitney U test to determine the relationship between the mean quantitative values and the ALNM. Multivariate logistic regression analyses followed by receiver operating characteristics (ROC) analysis for discriminating ALN status. A P value < 0.05 was considered statistically significant.

RESULTS: The short-diameter of lymph nodes (DLN) in ALNM group was significantly longer than that in the non-ALNM group (10.22 ± 3.58 mm vs. 5.28 ± 1.39 mm, P < 0.001). The optimal cutoff value was determined to be 5.78 mm, with an AUC of 0.894 (95 % CI: 0.838-0.939), a sensitivity of 86.7 %, and a specificity of 90.2 %. In syMRI quantitative parameters of breast tumors, T2tumor, ΔT2tumor and ΔPDtumor values showed statistically significant differences between the two groups (P < 0.05). T2tumor value had the best performance in discriminating ALN status (AUC = 0.712), and the optimal cutoff was 90.12 ms, the sensitivity and specificity were 65.0 % and 83.6 % respectively. In terms of syMRI quantitative parameters of lymph nodes, T1LN, T2LN, T1LN/T2LN, T2+LN and ΔT1LN values were significantly different between the two groups (P < 0.05), and their AUCs were 0.785, 0.840, 0.886, 0.702 and 0.754, respectively. Multivariate analyses indicated that the T1LN value was the only independent predictor of ALNM (OR=1.426, 95 % CI: 1.130-1.798, P = 0.039). The diagnostic sensitivity and specificity of T1LN was 86.7 % and 69.4 % respectively at the best cutoff point of 1371.00 ms. The combination of T1LN, T2LN, T1LN/T2LN, ΔT1LN and DLN had better performance for differentiating ALNM and non-ALNM, with AUCs of 0.905, 0.957, 0.964 and 0.897, respectively.

CONCLUSION: The quantitative parameters derived from syMRI have certain value for discriminating ALN status in invasive breast cancer, with T2tumor showing the highest diagnostic efficiency among breast lesions parameters. Moreover, T1LN acted as an independent predictor of ALNM.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Qu M, Feng W, Liu X, et al. Investigation of synthetic MRI with quantitative parameters for discriminating axillary lymph nodes status in invasive breast cancer. Eur J Radiol. 2024. PMID: 38604092. doi:10.1016/j.ejrad.2024.111452

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。